Hapbee Appoints New Leaders to Accelerate Women’s Wellness Through Frequency Healing Technology

Rhea-AI Summary

Hapbee (OTCQB: HAPBF) on October 27, 2025 appointed Jodie Jackson as Chief Neural Optimization Officer and Nancy H. Rothstein as Chief Sleep Officer to advance the company’s focus on women’s wellness using frequency-based digital wellness technology.

The company said it will develop new frequency routines for hormonal balance, stress management, and restorative sleep, pursue partnerships with women’s health networks and hotel groups, and target the FemTech market projected at USD 177 billion by 2033 with > 13% CAGR.

Positive

• Appointed 2 senior executives on Oct 27, 2025
• Targets FemTech market projected USD 177 billion by 2033
• Cited market growth of >13% CAGR to 2033
• Plans new frequency routines for hormonal and sleep support
• Announced partnerships with women’s health networks and hotel groups

Negative

• None.

Expanding focus into FemTech positions Hapbee to scale across a USD 177 billion market by uniting neuroscience, sleep optimization, and women-led innovation

VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (“Hapbee” or the “Company”) (TSXV: HAPB | OTCQB: HAPBF | FWB: HA1) — Hapbee Technologies Inc. (“Hapbee”), the pioneer in frequency-based digital wellness technology, today announced the appointment of Jodie Jackson as Chief Neural Optimization Officer and Nancy H. Rothstein as Chief Sleep Officer.

These additions mark a defining moment for Hapbee’s evolution as the company deepens its commitment to women’s wellness - a sector rapidly transforming the global health landscape. The initiative aligns with Hapbee’s long-term growth strategy to scale its proprietary frequency-based platform across the expanding FemTech market, which is projected to surpass USD 177 billion by 2033 with annual growth exceeding 13% CAGR (Straits Research, 2025).

Jodie Jackson, an authority in behavioral neuroscience and neuroplasticity, will lead Hapbee’s efforts to design personalized neural frequency protocols that address cognitive, emotional, and hormonal balance. Nancy H. Rothstein, MBA - internationally known as The Sleep Ambassador® - will oversee the development of Hapbee’s sleep programs and hospitality integrations, drawing on decades of experience in providing sleep information and education to optimize its impact on productivity, health, and life.

“No one is better equipped to inform the world - and shape the products that serve women - than women themselves,” said Riz Shah, Chairman of Hapbee Technologies. “As a father, son, sibling, and husband, I’ve seen firsthand how women shoulder immense emotional and physical demands. Supporting women’s wellness isn’t a marketing campaign; it’s essential to Hapbee’s mission and a major part of the next chapter of our growth. We’re incredibly proud to lead with empathy, science, and purpose.”

The company’s upcoming innovations will include new frequency routines designed to support hormonal harmony, stress management, and restorative sleep. Partnerships with women’s health networks, wellness practitioners, and hotel groups will further scale the reach of Hapbee’s technology globally.

“Everyone deserves technologies created with them in mind—not retrofitted after the fact, particularly for women,” said Nancy H. Rothstein, Chief Sleep Officer. “Sleep is critical to our health – and Hapbee offers a safe, natural path to restore rest, recharge energy, and reclaim emotional balance without consuming unnecessary pills or medicines.”

“It’s a privilege to join Hapbee in advancing women’s wellness through innovative frequency technologies,” added Jodie Jackson, Chief Neural Optimization Officer. “As a mother and working professional focused on unlocking human potential, I am excited to contribute to shaping how Hapbee’s technology can empower people to optimize focus, rest and resilience.”

About Hapbee

Hapbee Technologies Inc. is a leading wearable neuro-wellness company using proprietary ultra-low frequency technology to help people enhance their sleep, focus, and relaxation—safely and naturally. Hapbee’s products are trusted by wellness professionals, high performers, and consumers across more than 40 countries.

Forward‑Looking Information

This news release contains “forward‑looking information” within the meaning of applicable securities laws, including statements regarding Hapbee’s anticipated expansion in FemTech, and growth opportunities in wellness markets. Forward‑looking information is subject to risks and uncertainties that may cause actual results to differ materially. Hapbee undertakes no obligation to update forward‑looking information except as required by law.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, the receipt of applicable regulatory approvals, closing of the offering; anticipated product development, consumer confidence and general business, economic, competitive, political and social uncertainties. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results, except as may be required by applicable securities laws. There can be no assurance that forward-looking statements will prove to be accurate as actual results, and future events could differ materially from those anticipated in such statements.

Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

On behalf of the Board of Directors:

Kenny Adessky – Corporate Secretary

1 888 841 7086

invest@hapbee.com

www.hapbee.com

FAQ

Who did Hapbee (HAPBF) appoint on October 27, 2025?

Hapbee appointed Jodie Jackson as Chief Neural Optimization Officer and Nancy H. Rothstein as Chief Sleep Officer.

What market is Hapbee (HAPBF) targeting with its women’s wellness initiative?

Hapbee is targeting the FemTech market, projected at USD 177 billion by 2033 with > 13% CAGR.

What product developments did Hapbee (HAPBF) announce for women’s wellness?

The company plans new frequency routines aimed at hormonal harmony, stress management, and restorative sleep.

How will Hapbee (HAPBF) scale its women’s wellness offerings?

Hapbee plans partnerships with women’s health networks, wellness practitioners, and hotel groups to scale distribution.

Does the announcement include clinical or financial results for Hapbee (HAPBF)?

No; the announcement focuses on executive appointments, product plans, and market strategy without clinical or earnings data.